Monoclonal antibody to tumor necrosis factor-α prevents lethal endotoxin sepsis in adult rhesus monkeys

The Journal of Laboratory and Clinical Medicine

Volumn 120, Issue 4, 1992, Pages 574-588

  Fiedler, Volker B ^a,b,c   Loof, Ingo ^a,b,c   Sander, Erich ^a,b,c   Voehringer, Verena ^a,b,c   Galanos, Chris ^a,b,c   Fournel, Michael A ^a,b,c  

^a BAYER AG   (Germany)

^b MAX PLANCK INSTITUTE OF IMMUNOBIOLOGY AND EPIGENETICS   (Germany)

^c Miles Cutter Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; COMPLEMENT COMPONENT C3C; COMPLEMENT COMPONENT C4; ENDOTOXIN; GALACTOSAMINE; INTERLEUKIN 6; LEUKOCYTE ELASTASE; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ANTIBODY;

ACID BASE BALANCE; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CLOTTING; BLOOD GAS; CHINCHILLA; CONTROLLED STUDY; DRUG EFFICACY; ENDOTOXEMIA; ENZYME BLOOD LEVEL; HEART HEMODYNAMICS; HEMATOLOGY; HISTOPATHOLOGY; IMMUNOLOGY; MALE; MULTIPLE ORGAN FAILURE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY FUNCTION; RHESUS MONKEY;

ACID-BASE IMBALANCE; ANIMAL; ANTIBODIES, MONOCLONAL; BLOOD COAGULATION; CYTOKINES; GALACTOSAMINE; HEMODYNAMICS; IMMUNIZATION, PASSIVE; LEUKOCYTE ELASTASE; LIPOPOLYSACCHARIDES; MACACA MULATTA; MALE; PANCREATIC ELASTASE; RESPIRATION; SALMONELLA; SHOCK, SEPTIC; TUMOR NECROSIS FACTOR;

EID: 0026443181     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Gram-negative bacteremia. III. Reassessment of etiology, epidemiology, and ecology in 612 patients
2. Shock syndromes related to sepsis
3. Sepsis and septic shock: a review of laboratory models and a proposal
4. Some aspects of microcirculatory and metabolic changes in endotoxemia and in endotoxin tolerance
5. Serial quantitation of endotoxemia and bacteremia during therapy for gram-negative bacterial sepsis
6. Plasma endotoxin concentration in healthy primates and during E. coli-induced shock
7. Galactosamine-induced sensitization to the lethal effects of endotoxin
8. Selective uridine triphosphate deficiency induced by d-galactosamine in liver and reversed by pyrimidine nucleotide precursors
9. 1-antitrypsin carbohydrate composition
10. Multiple-organ failure syndrome
11. Plasma tumor necrosis factor in patients with septic shock: mortality rate, incidence of adult respiratory distress syndrome, and effects of methylprednisolone administration
12. Cachectin: more than a tumor necrosis factor
13. Shock and tissue injury induced by recombinant human cachectin
14. Detection of circulating tumor necrosis factor after endotoxin administration
15. Plasma tumor necrosis factor and mortality in critically ill septic patients
16. Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock
17. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia
18. 100 septic shock following therapy with antibody to tumor necrosis factor (TNFα)
19. Cachectin/tumor necrosis factor induces lethal shock and stress hormone responses in the dog
20. Activation of coagulation after administration of tumor necrosis factor to normal subjects
21. Consumptive thrombo-hemorrhagic disorders
22. Induction of lethality and tolerance by endotoxin are mediated by macrophages through tumor necrosis factor
23. Tumor necrosis factor mediates endotoxin shock: the protective effects of antibodies and cortisone
24. Erfassung und Auswertung atemmechanischer Grössen an isolierten Lungen mit Hilfe eines Datenerfassungs-systems
25. Determination of human thrombin-antithrombin III complex in plasma with enzyme-linked immunosorbent assay
26. Empfehlungen der Deutschen Gesellschaft für Klinische Chemie. Standardisierung von Methoden zur Bestimmung von Enzymaktivitẗen in biologischen Flüssigkeiten
27. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes
28. Functional discrimination between interleukin 6 and interleukin 1
29. 1-proteinase inhibitor and 2-macroglobulin
30. Proteinases and their inhibitors in septicemia: basic concepts and clinical implications
31. Automated computer analysis for enzyme-multiplied immunological technique
32. Tumor necrosis alone does not explain the lethal effect of lipopolysaccharide
33. Galactosamine hepatitis: key role of the nucleotide deficiency period in the pathogenesis of cell injury and cell death
34. Galactosamine-induced liver injury
35. Cardiovascular dysfunction in septic shock
36. Thrombin-antithrombin III complex in fulminant hepatic failure: evidence for disseminated intravascular coagulation and relationship to outcome
37. Direct evidence for Hageman factor (Factor XII) activation by bacterial lipopolysaccharide (endotoxins)
38. Laboratory and clinical evaluation of an assay of thrombin-antithrombin III complexes in plasma
39. A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramification for the complex physiology of TNF
40. Antibodies to cachectin/tumor necrosis factor reduce interleukin 1β and interleukin 6 appearance during lethal bacteremia
41. Elastase-α1-Proteinaseinhibitor-Komplex: Ein Indikator für pathobiochemische Veränderungen in der Sepsis und nach Polytrauma